Addressing hepatic metastases in ovarian cancer: Recent advances in treatment algorithms and the need for a multidisciplinary approach

The lifetime risk for ovarian cancer incidence is 1.39% and the lifetime risk of death is 1.04%. Most ovarian cancer patients are diagnosed at advanced stages (III, IV) because there were no specific symptoms or existing screening tests. Liver metastases have been found in up to 50% of patients dyin...

Descripción completa

Detalles Bibliográficos
Autores principales: Adamopoulou, Konstantina, Gkamprana, Athanasia M, Patsouras, Konstantinos, Halkia, Evgenia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473491/
https://www.ncbi.nlm.nih.gov/pubmed/34630879
http://dx.doi.org/10.4254/wjh.v13.i9.1122
_version_ 1784575002818904064
author Adamopoulou, Konstantina
Gkamprana, Athanasia M
Patsouras, Konstantinos
Halkia, Evgenia
author_facet Adamopoulou, Konstantina
Gkamprana, Athanasia M
Patsouras, Konstantinos
Halkia, Evgenia
author_sort Adamopoulou, Konstantina
collection PubMed
description The lifetime risk for ovarian cancer incidence is 1.39% and the lifetime risk of death is 1.04%. Most ovarian cancer patients are diagnosed at advanced stages (III, IV) because there were no specific symptoms or existing screening tests. Liver metastases have been found in up to 50% of patients dying of advanced ovarian cancer. Recent studies indicate the need for a multidisciplinary approach from initial diagnosis to oncologic surgery and chemotherapy treatment, mandating the involvement of gynecologic oncologists, surgical oncologist, medical oncologists, hepatobiliary surgeons, and interventional radiologists.
format Online
Article
Text
id pubmed-8473491
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-84734912021-10-08 Addressing hepatic metastases in ovarian cancer: Recent advances in treatment algorithms and the need for a multidisciplinary approach Adamopoulou, Konstantina Gkamprana, Athanasia M Patsouras, Konstantinos Halkia, Evgenia World J Hepatol Minireviews The lifetime risk for ovarian cancer incidence is 1.39% and the lifetime risk of death is 1.04%. Most ovarian cancer patients are diagnosed at advanced stages (III, IV) because there were no specific symptoms or existing screening tests. Liver metastases have been found in up to 50% of patients dying of advanced ovarian cancer. Recent studies indicate the need for a multidisciplinary approach from initial diagnosis to oncologic surgery and chemotherapy treatment, mandating the involvement of gynecologic oncologists, surgical oncologist, medical oncologists, hepatobiliary surgeons, and interventional radiologists. Baishideng Publishing Group Inc 2021-09-27 2021-09-27 /pmc/articles/PMC8473491/ /pubmed/34630879 http://dx.doi.org/10.4254/wjh.v13.i9.1122 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Minireviews
Adamopoulou, Konstantina
Gkamprana, Athanasia M
Patsouras, Konstantinos
Halkia, Evgenia
Addressing hepatic metastases in ovarian cancer: Recent advances in treatment algorithms and the need for a multidisciplinary approach
title Addressing hepatic metastases in ovarian cancer: Recent advances in treatment algorithms and the need for a multidisciplinary approach
title_full Addressing hepatic metastases in ovarian cancer: Recent advances in treatment algorithms and the need for a multidisciplinary approach
title_fullStr Addressing hepatic metastases in ovarian cancer: Recent advances in treatment algorithms and the need for a multidisciplinary approach
title_full_unstemmed Addressing hepatic metastases in ovarian cancer: Recent advances in treatment algorithms and the need for a multidisciplinary approach
title_short Addressing hepatic metastases in ovarian cancer: Recent advances in treatment algorithms and the need for a multidisciplinary approach
title_sort addressing hepatic metastases in ovarian cancer: recent advances in treatment algorithms and the need for a multidisciplinary approach
topic Minireviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473491/
https://www.ncbi.nlm.nih.gov/pubmed/34630879
http://dx.doi.org/10.4254/wjh.v13.i9.1122
work_keys_str_mv AT adamopouloukonstantina addressinghepaticmetastasesinovariancancerrecentadvancesintreatmentalgorithmsandtheneedforamultidisciplinaryapproach
AT gkampranaathanasiam addressinghepaticmetastasesinovariancancerrecentadvancesintreatmentalgorithmsandtheneedforamultidisciplinaryapproach
AT patsouraskonstantinos addressinghepaticmetastasesinovariancancerrecentadvancesintreatmentalgorithmsandtheneedforamultidisciplinaryapproach
AT halkiaevgenia addressinghepaticmetastasesinovariancancerrecentadvancesintreatmentalgorithmsandtheneedforamultidisciplinaryapproach

Ejemplares similares